NCT00922636 A Study of Pediatric Patients With Attention Deficit/Hyperactivity Disorder Status COMPLETED Phase PHASE2/PHASE3
NCT00920582 Protege Encore Study- Clinical Trial of Teplizumab (MGA031) in Children and Adults With Recent-Onset Type 1 Diabetes Mellitus Status TERMINATED Phase PHASE3
NCT00918567 Impact of Strattera and Behavior Therapy on the Home and School Functioning of Children With ADHD Status COMPLETED Phase PHASE4
NCT00918203 A Study of Paclitaxel/Carboplatin With or Without Olaratumab (IMC-3G3) in Previously Untreated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) Status COMPLETED Phase PHASE2
NCT00917384 Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Participants With Gastric Cancer and Adenocarcinoma Status COMPLETED Phase PHASE3
NCT00917267 A Study to Examine the Effects of Exenatide Once-Weekly Injection on Glucose Control and Safety in Asian Subjects Status COMPLETED Phase PHASE3
NCT00916630 Treatment of Recurrent Primary or Secondary Central Nervous System (CNS) Lymphoma With ALIMTA (Pemetrexed) Status COMPLETED Phase PHASE1
NCT00913835 A Study of Liposomal Doxorubicin With or Without Olaratumab (IMC-3G3) in Platinum-Refractory or Resistant Advanced Ovarian Cancer Status COMPLETED Phase PHASE2
NCT00910299 Testing Platelet Reactivity In Patients Undergoing Elective Stent Placement on Clopidogrel to Guide Alternative Therapy With Prasugrel (TRIGGER-PCI) Status TERMINATED Phase PHASE2
NCT00906373 A Study of IMC-A12 in Combination With Sorafenib in Participants With Advanced Cancer of the Liver Status COMPLETED Phase PHASE2
NCT00906282 Preoperative Pemetrexed and Carboplatin for Select Stage IB, II, and III Non-Squamous Non-Small-Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00905372 Effect of LY2062430 on the Progression of Alzheimer's Disease Status COMPLETED Phase PHASE3
NCT00904683 Effect of LY2062430 on the Progression of Alzheimer's Disease Status COMPLETED Phase PHASE3
NCT00895648 Pemetrexed (ALIMTA) Plus Cisplatin Followed by Surgery and Radiation Therapy for Mesothelioma Status TERMINATED Phase PHASE2
NCT00895180 Ramucirumab or Anti-PDGFR Alpha Monoclonal Antibody IMC-3G3 in Treating Patients With Recurrent Glioblastoma Multiforme Status COMPLETED Phase PHASE2
NCT00894504 Panitumumab, Gemcitabine and Carboplatin in Triple-Negative Metastatic Breast Cancer Status COMPLETED Phase PHASE2
NCT00894322 A Study to Examine the Pharmacokinetics, Tolerability, Safety and Efficacy of Exenatide Once Weekly Suspension Status COMPLETED Phase PHASE1/PHASE2
NCT00889369 Duloxetine for Major Depression in Peri-/Postmenopausal Women Status UNKNOWN Phase PHASE4